Overall, the study evidence did not support an association between PD-L1 expression and patient baseline information such as age, gender, and tumor stage in lung cancer (8), but higher expression levels of PD-L1 were associated with poor prognosis in lung cancer (23) and melanoma (24). This evidence concerns the gene CD274 and lung carcinoma.